Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
+0.010 (0.25%)
At close: Aug 21, 2026, 4:00 PM EDT
4.127
+0.087 (2.15%)
After-hours: Aug 21, 2026, 7:30 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
40135012514012164
Market Cap Growth
537.24%179.54%-10.81%16.23%87.36%-38.49%
Enterprise Value
27030568577928
Last Close Price
4.044.0022.0125.1629.7968.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
25.289.9648.93---
PB Ratio
2.501.885.652.751.631.00
P/TBV Ratio
3.202.19-4.162.131.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
17.038.6826.73---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.500.423.531.140.520.62
Net Debt / Equity Ratio
-0.84-0.94-1.08-1.09-1.12-0.65
Net Debt / EBITDA Ratio
1.662.240.170.520.950.56
Net Debt / FCF Ratio
1.562.050.180.581.080.59
Asset Turnover
0.090.160.02---
Inventory Turnover
0.681.58----
Quick Ratio
10.859.853.165.025.505.89
Current Ratio
11.3010.163.415.345.766.27
Return on Equity (ROE)
-113.08%-75.99%-102.26%-161.67%-135.58%-129.28%
Return on Assets (ROA)
-28.15%-22.86%-60.18%-44.38%-40.36%-39.24%
Return on Capital Employed (ROCE)
-34.50%-30.20%-124.50%-86.40%-66.10%-73.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.50%-22.64%-29.93%-72.12%-77.78%-137.70%
FCF Yield
-20.91%-24.48%-104.89%-68.84%-63.97%-111.04%
Buyback Yield / Dilution
-1374.07%-531.04%-13.08%-179.91%-146.71%-28.25%
SEC Filings: 10-K · 10-Q